CLIA dsDNA

Chemiluminescence kit for the detection of dsDNA antibodies in human serum or plasma.

Coming soon
Catalog Number: CL-DNA100
Size: 100 tests
Regulatory status: CE IVD
Clinical topic: Immunology & Autoimmune Diseases
CLIA dsDNA
  • Detection of anti-dsDNA antibodies, IgG class
  • To help diagnose and monitor systemic lupus erythematodes (SLE)
  • Evaluating patients with clinical features or at-risk for SLE
  • Intended for human serum and plasma
  • Purified native human dsDNA used as the antigen

Antibodies to double-stranded DNA (anti-dsDNA) fall in the group of antinuclear antibodies. Anti-dsDNA is included in the Systemic Lupus International Collaborating Clinics classification criteria (SLICC) for SLE and is also outlined in the classification criteria for SLE of the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR). The antibodies are considered highly specific for systemic lupus erythematosus (SLE). Antibodies to dsDNA are present during the active phase of the disease and are associated with lupus nephritis.

Testing for IgG antibodies to dsDNA is indicated in patients positive for a homogeneous structure of anti-cell antibodies (i.e., Antinuclear Antibodies: ANA) using the HEp-2 substrate by indirect immunofluorescence assay (IFA) along with SLE-compatible clinical features. The serum concentrations of anti-dsDNA may fluctuate with SLE disease activity. An increase in antibody levels may be associated with flares while decline or negative results may indicate response to treatment or disease remission.

Lower titres and low-affinity anti-dsDNA may be present in patients with other systemic diseases / immunopathological conditions (e.g. viral infections), very rarely also in healthy individuals.

Antigen Used: Purified native human dsDNA.

Technical specifications

Technical data
References
Related Products
Downloads

Technical data

Assay stability (on board)30 days
Sample matrix Serum, Plasma
Assay/kit contentReagent Cartridge with specific reagents for the assay, magnetic particles, calibrators
Complementary productsWash buffer, Anchor® Tips, Stackable cuvettes, Trigger solutions

References

References to CLIA dsDNA

  • Aringer M, Johnson SR. Systemic Lupus Erythematosus Classification and Diagnosis. Rheum Dis Clin North Am. 2021 Aug;47(3):501-511. doi: 10.1016/j.rdc.2021.04.011. Epub 2021 Jun 10. PMID: 34215376.
    See more on PubMed
  • Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug;64(8):2677-86. doi: 10.1002/art.34473. PMID: 22553077; PMCID: PMC3409311.
    See more on PubMed
  • Fox BJ, Hockley J, Rigsby P, Dolman C, Meroni PL, Rönnelid J. A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation. Ann Rheum Dis. 2019 Dec;78(12):1677-1680. doi: 10.1136/annrheumdis-2019-215845. Epub 2019 Sep 5. PMID: 31488407; PMCID: PMC6900249.
    See more on PubMed
  • Rekvig OP. The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be. Front Immunol. 2019 May 15;10:1104. doi: 10.3389/fimmu.2019.01104. PMID: 31156647; PMCID: PMC6529578.
    See more on PubMed
  • Bragazzi NL, Watad A, Damiani G, Adawi M, Amital H, Shoenfeld Y. Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature. Expert Rev Mol Diagn. 2019 Nov;19(11):969-978. doi: 10.1080/14737159.2019.1665511. Epub 2019 Sep 13. PMID: 31516059.
    See more on PubMed
  • Lou H, Wojciak-Stothard B, Ruseva MM, Cook HT, Kelleher P, Pickering MC, Mongkolsapaya J, Screaton GR, Xu XN. Autoantibody-dependent amplification of inflammation in SLE. Cell Death Dis. 2020 Sep 9;11(9):729. doi: 10.1038/s41419-020-02928-6. PMID: 32908129; PMCID: PMC7481301.
    See more on PubMed

Downloads

Find documents for the batch

Do you want to learn more?
We're here for you

Please fill in
all fields
marked *
Up
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.
Agree